article thumbnail

Changing Faces: pharma supplier, DTx, and non-profit hires from November 2022

pharmaphorum

Digital therapeutics company Cognoa, which focuses on paediatric behavioural health, announced the appointment of Dr Sharief Taraman as its new CEO. Drawing on 25 years in clinical research, White will oversee Saama’s project delivery teams. We’ve rounded up some highlights below. Digital therapeutics hires.

article thumbnail

Cognoa preps FDA filing for digital autism diagnostic

pharmaphorum

In the US, it is estimated that one in five children are living with a diagnosable behavioural health disorder, however, only 21% of children who are diagnosed receive treatment.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BI, Click Therapeutics expand collaboration to PDT for schizophrenia

pharmaphorum

Roughly half of all patients exhibit co-occurring mental and/or behavioural health disorders. The serious mental health condition alters a person’s perception of reality and impacts how they think, feel, and behave. Currently there remains a significant unmet need due to lack of access to psychosocial intervention therapies.

article thumbnail

Applied Virtual Reality in Healthcare: A comprehensive book on medical XR

pharmaphorum

Immersive technology can also help improve assessments of the effectiveness of treatment, particularly regarding behavioural health where a patient’s results are often subjective. We will see a new generation of better assessments, which will empower better research,” Greenleaf said. About the interviewee.

article thumbnail

Partnering to advance digital therapeutics offerings

pharmaphorum

Gani started BehaVR in 2016 to create DTx for mental and behavioural health. He says after a meeting between him and a leader at Sumitomo in 2018 or 2019, it became apparent both companies believed in the power of VR in mental health care. Configuring a collaboration. We just hadn’t found each other.

article thumbnail

IVRHA 2022: Exhibiting pioneers of medical XR

pharmaphorum

In a crowd of 200 attendees, guests included medical XR start-ups, hospitals, and research universities from around the globe. In 2021, the behavioural health company and Sumitomo Dainippon Pharma Co.

article thumbnail

What we’re expecting in 2021, and beyond…

pharmaphorum

There is an opportunity to address this at scale with digital tools and techniques, and expand support into just about any therapeutic area through the holistic integration of mental and behavioural health solutions that improve patient care. Integration of telehealth strategy into commercial models.